Proteomic and bioinformatic analyses of possible target-related proteins of gambogic acid in human breast carcinoma MDA-MB-231 cells

Chinese Journal of Natural Medicines

Volumn 13, Issue 1, 2015, Pages 41-51

  Li, Dong ^a,b   Song, Xiao Yi ^b,c   Yue, Qing Xi ^b,c   Cui, Ya Jun ^c   Liu, Miao ^b   Feng, Li Xing ^b   Wu, Wan Ying ^b   Jiang, Bao Hong ^b   Yang, Min ^b   Qu, Xiao Bo ^a   Liu, Xuan ^b   Guo, De An ^b  

^a CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti cancer; Bioinformatic; Gambogic acid; MDA MB 231 cells; Proteomic

Indexed keywords

ANTINEOPLASTIC AGENT; CALUMENIN; CYTOKERATIN 18; GAMBOGIC ACID; PROTEASOME; PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VIMENTIN; CALCIUM BINDING PROTEIN; CALU PROTEIN, HUMAN; DEUBIQUITINASE; KRT18 PROTEIN, HUMAN; XANTHONE DERIVATIVE;

APOPTOSIS; ARTICLE; BIOINFORMATICS; BIOLOGICAL ACTIVITY; BREAST CANCER CELL LINE; BREAST CARCINOMA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; MTT ASSAY; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEIN TRANSPORT; PROTEOMICS; QUANTITATIVE ANALYSIS; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; BIOLOGY; BREAST NEOPLASMS; CELL MIGRATION ASSAY; CYTOSKELETON; DRUG EFFECTS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; MIGRATION INHIBITION; OXIDATION REDUCTION REACTION; PROCEDURES; PROTEIN SYNTHESIS; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MIGRATION INHIBITION; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; CYTOSKELETON; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; KERATIN-18; OXIDATION-REDUCTION; PROTEIN BIOSYNTHESIS; PROTEIN TRANSPORT; PROTEOMICS; TRANSCRIPTION, GENETIC; UBIQUITIN-SPECIFIC PROTEASES; VIMENTIN; XANTHONES;

EID: 84924959873     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(15)60005-X     Document Type: Article

References (45)

1. Boran AD, Iyengar R Systems pharmacology [J]. Mt Sinai J Med 2010, 77(4):333-344.
2. Chi Y, Zhan XK, Yu H, et al. An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors [J]. Chin Med J (Engl) 2013, 126(9):1642-1646.
3. Xu J, Zhou M, Ouyang J, et al. Gambogic acid induces mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in mantle cell lymphoma JeKo-1 cells [J]. Chin J Cancer Res 2013, 25(2):183-191.
4. Lu N, Hui H, Yang H, et al. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway [J]. Eur J Pharm Sci 2013, 49(2):220-226.
5. Rahman MA, Kim NH, Huh SO Cytotoxic effect of gambogic acid on SH-SY5Y neuroblastoma cells is mediated by intrinsic caspase-dependent signaling pathway [J]. Mol Cell Biochem 2013, 377(1-2):187-196.
6. Yang LJ, Chen Y New targets for the antitumor activity of gambogic acid in hematologic malignancies [J]. Acta Pharmacol Sin 2013, 34(2):191-198.
7. Li C, Qi Q, Lu N, et al. Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells [J]. Biochem Cell Biol 2012, 90(6):718-730.
8. Zhang L, Yi Y, Chen J, et al. Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells [J]. Biochem Biophys Res Commun 2010, 403(3-4):282-287.
9. Nie F, Zhang X, Qi Q, et al. Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells [J]. Toxicology 2009, 260(1-3):60-67.
10. Yu J, Guo QL, You QD, et al. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells [J]. Carcinogenesis 2007, 28(3):632-638.
11. Anantachoke N, Tuchinda P, Kuhakarn C, et al. Prenylated caged xanthones: chemistry and biology [J]. Pharm Biol 2012, 50(1):78-91.
12. Wang S, Wu X, Tan M, et al. Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy [J]. J Ethnopharmacol 2012, 140(1):33-45.
13. He XY, Liu XJ, Chen X, et al. Gambogic acid induces EGFR degradation and Akt/mTORC1 inhibition through AMPK dependent-LRIG1 upregulation in cultured U87 glioma cells [J]. Biochem Biophys Res Commun 2013, 435(3):397-402.
14. Felth J, Lesiak-Mieczkowska K, D'Arcy P, et al. Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin- proteasome system [J]. Invest New Drugs 2013, 31(3):587-598.
15. Li X, Liu S, Huang H, et al. Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo [J]. Cell Rep 2013, 3(1):211-222.
16. Xin ZF, Shen CC, Tao LJ, et al. Gambogic acid inhibits invasion of osteosarcoma via upregulation of TIMP-1 [J]. Int J Mol Med 2013, 31(1):105-112.
17. Wang X, Deng R, Lu Y, et al. Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation [J]. Basic Clin Pharmacol Toxicol 2013, 112(1):25-33.
18. Zhu X, Zhang H, Lin Y, et al. Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors [J]. J chemother 2009, 21(6):666-672.
19. Chen J, Gu HY, Lu N, et al. Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells [J]. Life Sci 2008, 83(3-4):103-109.
20. Yi T, Yi Z, Cho SG, et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling [J]. Cancer Res 2008, 68(6):1843-1850.
21. + channel by gambogic acid [J]. J biol chem 2009, 284(23):15432-15438.
22. Shu W, Chen Y, Li R, et al. Involvement of regulations of nucleophosmin and nucleoporins in gambogic acid-induced apoptosis in Jurkat cells [J]. Basic Clin Pharmacol Toxicol 2008, 103(6):530-537.
23. Yue QX, Xie FB, Guan SH, et al. Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes [J]. Cancer science 2008, 99(7):1461-1470.
24. Qi Q, Lu N, Wang XT, et al. Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells [J]. Biochem Cell Biol 2008, 86(5):386-395.
25. Yue QX, Cao ZW, Guan SH, et al. Proteomic characterization of the cytotoxic mechanism of ganoderic acid D and computer automated estimation of the possible drug-target network [J]. Mol Cell Proteomics 2008, 7(5):949-961.
26. Feng LX, Jing CJ, Tang KL, et al. Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis [J]. Proteomics 2011, 11(8):1473-1485.
27. Ma C, Yao Y, Yue QX, et al. Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B [J]. PLoS ONE 2011, 6(2):e14692.
28. Feng LX, Zhang DM, Fan CY, et al. ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network [J]. Cell Death Dis 2013, 4:e715.
29. Bensimon A, Schmidt A, Ziv Y, et al. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage [J]. Sci Signal 2010, 3(151):rs3.
30. Zhu QS, Rosenblatt K, Huang KL, et al. Vimentin is a novel AKT1 target mediating motility and invasion [J]. Oncogene 2011, 30(4):457-470.
31. Weng YR, Cui Y, Fang JY Biological functions of cytokeratin 18 in cancer [J]. Mol Cancer Res 2012, 10(4):485-493.
32. Traina F, Favaro PM, Medina Sde S, et al. ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells [J]. Biochim Biophys Acta 2006, 1762(9):828-834.
33. Tani K, Shibata M, Kawase K, et al. Mapping of functional domains of gamma-SNAP [J]. J Biol Chem 2003, 278(15):13531-13538.
34. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions [J]. Blood 2004, 103(6):2096-2104.
35. Khalil AA Biomarker discovery: a proteomic approach for brain cancer profiling [J]. Cancer Sci 2007, 98(2):201-213.
36. di Salvo ML, Safo MK, Musayev FN, et al. Structure and mechanism of Escherichia coli pyridoxine 5'-phosphate oxidase [J]. Biochim Biophys Acta 2003, 1647(1-2):76-82.
37. Chang HJ, Lee MR, Hong SH, et al. Identification of mitochondrial FoF1-ATP synthase involved in liver metastasis of colorectal cancer [J]. Cancer Sci 2007, 98(8):1184-1191.
38. Janssen U, Stoffel W Disruption of mitochondrial beta- oxidation of unsaturated fatty acids in the 3, 2-trans-enoyl- CoA isomerase- deficient mouse [J]. J Biol Chem 2002, 277(22):19579-19584.
39. Bénit P, Slama A, Cartault F, et al. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome [J]. J Med Genet 2004, 41(1):14-17.
40. Castillo-Acosta VM, Estévez AM, Vidal AE, et al. Depletion of dimeric all-alpha dUTPase induces DNA strand breaks and impairs cell cycle progression in Trypanosoma brucei [J]. Int J Biochem Cell Biol 2008, 40(12):2901-2913.
41. Hathurusinghe HR, Goonetilleke KS, Siriwardena AK, et al. Current status of tumorM2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy [J]. Ann SurgOncol 2007, 14(10):2714-2720.
42. Mkrtchian S, Sandalova T ERp29, an unusual redox-inactive member of the thioredoxin family [J]. Antioxid Redox Signal 2006, 8(3-4):325-337.
43. Park S, Yoon SY, Kim KE, et al. Interleukin-18 induces transferrin expression in breast cancer cell line MCF-7 [J]. Cancer Lett 2009, 286(2):189-195.
44. Yang LJ, Chen Y, He J, et al. Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI- 8226 multiple myeloma cells via the accumulation of ROS [J]. Oncol Lett 2012, 3(5):1159-1165.
45. Kasibhatla S, Jessen KA, Maliartchouk S, et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid [J]. Proc Natl Acad Sci USA 2005, 102(34):12095-12100.